Systems and methods for measuring cell signaling protein activity
US-2024230643-A9 · Jul 11, 2024 · US
US10584159B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10584159-B2 |
| Application number | US-201515512267-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 21, 2015 |
| Priority date | Sep 19, 2014 |
| Publication date | Mar 10, 2020 |
| Grant date | Mar 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Bioluminescence resonance energy transfer (BRET) biosensors for assessing the intracellular localization, internalization and trafficking into cellular compartments of proteins such as receptors, and other biomolecules such as second messengers, are disclosed. These biosensors, which are dependent on the concentration/density of the BRET donor and acceptor in cellular compartments rather that specific protein-protein interactions, use a Renilla GFP/Luc BRET pair, which allows the robust and reproducible monitoring of protein trafficking/localization, with a sensitivity compatible with high-throughput screening (HTS). The use of these biosensors for various applications, including assessing/monitoring protein endocytosis, recycling and intracellular trafficking, receptor maturation/rescue by pharmacological chaperones, various endocytosis/exocytosis processes, activation/inhibition, as well as biomolecule concentration/density in different cellular compartments, is also disclosed.
Opening claim text (preview).
What is claimed is: 1. A biosensor for assessing the trafficking and/or localization of a protein of interest comprising; a first component comprising said protein of interest tagged with a Renilla green fluorescent protein ( Renilla GFP) or a Renilla luciferase protein ( Renilla Luc); a second component comprising a cellular compartment targeting moiety tagged with a Renilla GFP or a Renilla Luc, wherein said cellular compartment targeting moiety is: (i) a plasma membrane (PM) targeting moiety comprising the amino acid sequence MGCIKSKGKDS(SEQ ID NO:1), GKKKKKKSKTKCVIM (SEQ ID NO:7), CMSCKCVLS (SEQ ID NO:47), CMSCKCCIL (SEQ ID NO:43), or SPKKGLLQRLFKRQHQNNSKS (SEQ ID NO:8); or (ii) an endosomal targeting moiety comprising residues 739 to 806 of human endofin (SEQ ID NO:20); wherein if said protein of interest is tagged with said Renilla GFP, said cellular compartment targeting moiety is tagged with said Renilla Luc, and if said protein of interest is tagged with said Renilla Luc, said cellular compartment targeting moiety is tagged with said Renilla GFP. 2. The biosensor of claim 1 , wherein said protein of interest is tagged with said Renilla Luc and said cellular compartment targeting moiety is tagged with said Renilla GFP. 3. The biosensor of claim 1 , wherein said protein of interest is i) a signalling polypeptide or a fragment thereof, ii) a protein recruited to the plasma membrane upon stimulation of a receptor, or a fragment thereof, iii) a protein sequestered away from the plasma membrane upon stimulation of a receptor, or a fragment thereof, or iv) a cell surface receptor or a fragment thereof. 4. The biosensor of claim 3 , wherein said cell surface receptor is a G protein-coupled receptor (GPCR) or a receptor tyrosine kinase (RTK). 5. The biosensor of claim 1 , which comprises said PM targeting moiety. 6. The biosensor of claim 1 , wherein said PM targeting moiety is fused to the C-terminal end of said Renilla Luc or said Renilla GFP. 7. The biosensor of claim 1 , which comprises said endosomal targeting moiety. 8. The biosensor of claim 1 , wherein said endosomal targeting moiety is fused to the C-terminal end of said Renilla Luc or said Renilla GFP; and/or said protein of interest is fused to the N-terminal end of said Renilla Luc or said Renilla GFP. 9. The biosensor of claim 1 , wherein said first and second component are covalently linked through a flexible linker. 10. A method for determining whether an agent modulates the trafficking of a protein of interest in a cell, said method comprising: measuring the BRET signal in the biosensor of claim 1 in the presence and absence of said agent; wherein a difference in said BRET signal in the presence of said agent relative to the absence thereof is indicative that said agent modulates the trafficking of said protein of interest in said cell. 11. The biosensor of claim 1 , wherein said Renilla Luc is Renilla reniformis luciferase II (RlucII) and/or said Renilla GFP is a Renilla reniformis GFP (rGFP). 12. The biosensor of claim 3 , wherein said signalling protein or fragment thereof is a G protein effector or a fragment thereof, a β-arrestin polypeptide or a fragment thereof, a G protein subunit polypeptide or a fragment thereof, an adaptor protein or a fragment thereof, or a Rho-binding polypeptide or a fragment thereof. 13. The biosensor of claim 12 , wherein said signalling protein or fragment thereof is an adaptor protein or a fragment thereof. 14. The biosensor of claim 13 , wherein said adaptor protein or fragment thereof comprises at least one SH2 and/or SH3 domains. 15. The biosensor of claim 3 , wherein said signalling protein or fragment thereof is a polypeptide that binds to a second messenger or to a second messenger precursor. 16. The biosensor of claim 15 , wherein said second messenger precursor is phosphatidylinositol 4,5-bisphosphate (PIP 2 ). 17. The biosensor of claim 16 , wherein said signalling protein or fragment thereof comprises a Pleckstrin homology (PH) domain. 18. The biosensor of claim 15 , wherein said second messenger is diacylglycerol (DAG). 19. The biosensor of claim 18 , wherein said signalling protein or fragment thereof comprises a phorbol esters/diacylglycerol binding domain. 20. The biosensor of claim 12 , wherein the signalling protein or fragment thereof is a β-arrestin polypeptide or a fragment thereof fused to the N-terminal of said Renilla Luc, and the cellular compartment targeting moiety is a plasma membrane (PM) targeting moiety or an endosomal targeting moiety, fused to the C-terminal of said Renilla GFP. 21. The biosensor of claim 4 , wherein the GPCR is fused to the N-terminal of said Renilla Luc, and the cellular compartment targeting moiety is fused to the C-terminal of said Renilla GFP. 22. The biosensor of claim 1 , wherein said biosensor is comprised within a cell. 23. The biosensor of claim 1 , wherein the protein of interest is a Grb2 polypeptide or a fragment thereof. 24. The biosensor of claim 23 , wherein the Grb2 polypeptide comprises the amino acid sequence of SEQ ID NO: 24. 25. The biosensor of claim 16 , wherein the signalling protein or fragment thereof comprising a PH domain is a phospholipase C delta 1 (PLCδ1) protein or a fragment thereof. 26. The biosensor of claim 25 , wherein the PLCδ1 protein or fragment thereof comprises the amino acid sequence of SEQ ID NO: 25.
on sub-cellular localization · CPC title
containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title
G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.